Oryn Therapeutics
This company develops synthetic cyclic peptides based on theta-defensins to treat inflammatory, autoimmune, and infectious diseases. Their technology aims to overcome drug resistance and induce remission in conditions like rheumatoid arthritis.
- Biotechnology
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops synthetic cyclic peptides based on theta-defensins to treat inflammatory, autoimmune, and infectious diseases. Their technology aims to overcome drug resistance and induce remission in conditions like rheumatoid arthritis.